Reconcile Chewable Tablets for Dogs - 16 mg, 64 mg, 90 Tablets
- Quantity:
- 90 Count
About this item
Reconcile Flavored Chewable Tablets for Dogs are formulated to help manage separation anxiety in dogs. These once-daily fluoxetine hydrochloride tablets work alongside behavior modification techniques to alleviate symptoms and promote a calmer state of mind.
Symptoms of separation anxiety include: Destructive behavior, Inappropriate elimination, Excessive whining or barking, Excessive drooling, Pacing, Refusing to eat.
Key Benefits:
Formulated For: For use in puppies (ages 8 weeks and up; 8.8 pounds and up) and dogs.
Why Use It? Diminishes severity and frequency of symptoms of anxiety
Aids in behavior modification to reduce separation anxiety
Non-sedative
Health Consideration: Separation anxiety in dogs.
How is Medication Given? RECONCILE chewable tablets are indicated for the treatment of canine separation anxiety in conjunction with a behavior modification plan. The recommended dose of RECONCILE chewable tablets is 1-2 mg/kg (0.5-0.9 mg/lb) administered once daily, in conjunction with a behavior modification plan. A typical behavior modification plan consists of the pet owner implementing standard training techniques based on principles such as rewarding appropriate behavior; coming and going in a manner that does not elicit inappropriate responses from the dog; and teaching the dog to be content while alone. Reconcile Administration for dogs and puppies (8 weeks or older)
What Results Can I Expect? The active ingredient in Reconcile Tablet is fluoxetine hydrochloride, a selective serotonin reuptake inhibitor that helps to balance the chemicals in your pet that lead to unwanted behaviors, depression, panic, and anxiety.
What Form Does Medication Come In? Bottle
Manufacturer: PRN Pharmacal, Inc.
Common Brand Name: Reconcile
Dose and Administration: RECONCILE chewable tablets are indicated for the treatment of canine separation anxiety in conjunction with a behavior modification plan. The recommended dose of RECONCILE chewable tablets is 1-2 mg/kg (0.5-0.9 mg/lb) administered once daily, in conjunction with a behavior modification plan. A typical behavior modification plan consists of the pet owner implementing standard training techniques based on principles such as rewarding appropriate behavior; coming and going in a manner that does not elicit inappropriate responses from the dog; and teaching the dog to be content while alone. Reconcile Administration for dogs and puppies (8 weeks or older)
Weight Dosage:
8.8 â 17.6 lbs 8 mg 1 Tablet
17.7 - 35.2 lbs 16mg 1 Tablet
35.3 - 70.4 lbs 32mg 1 Tablet
70.5 - 140.8 lbs 64mg 1 Tablet
Side Effects: Potential side effects of Reconcile include seizure, diarrhea, tremors, vomiting, depression, lethargy, decreased appetite. If you notice any of these symptoms, contact your vet.
Precautions: Do not administer Reconcile to dogs who are hypersensitive to SSRIs, such as fluoxetine HLI. Reconcile should not be used in combination with medications that lower seizure thresholds. These include chlorpromazine, acepromazine, or phenothiazines. If a dog has a history of seizures or has been diagnosed with epilepsy, Reconcile should not be given. Do not use with any MAOI drug, including amitraz, selegiline hydrochloride (L-deprenyl) or within 2 weeks of discontinuing such medications. After discontinuing, observe a 6-week washout period before administering medications that may cause adverse reactions with norfluoxetine or fluoxetine. Keep out of reach of animals and children.
Storage Recommendations: Store at room temp 4 degrees C (39 degrees F) and 25 degrees C (77 degrees F), avoiding excess heat or cold.
In Case of Overdose: If you suspect an overdose, contact your vet or emergency medical facility immediately.
Is Prescription from a Vet Required? Yes
From the manufacturer
